Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a wide variety ...

Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...

3D printing is all well and good if you want one of something, but if you want lots of plastic parts that are all largely identical, you should consider injection molding. You can pay someone to ...

Bevacizumab (Avastin). This is a widely used and cost-effective drug for wet AMD injections. The FDA approved it to treat colon cancer in 2004. (It works by stopping the growth of new blood vessels.) ...

Caretaker Punjab Minister for Specialized Health Care Dr Javed Akram says so far sixty-eight patients have been affected due to Avastin injection in the province. Addressing the joint press conference ...

Ranibizumab vs Bevacizumab: Findings From the IVAN Trial One-year results are in for the IVAN trial comparing ranibizumab with bevacizumab for the treatment of neovascular age-related macular ...

Anti-VEGF consists of medicated eye injections that target the underlying causes of wet AMD. This treatment is also sometimes recommended for other retinal conditions, such as macular edema caused ...

These injections deliver medication such as the new geographic atrophy drugs Syfovre ... and a less concentrated 0.3 mg dose for treating diabetic macular edema goes for around $1,170 per dose.

Punjab government has constituted a five-member committee to review the case of eye infection due to Avastin injection. The committee will submit its report within three days and will also put forward ...

The MARINA trial randomized subjects with minimally classic or occult without classic subfoveal CNV to one of three treatment arms: monthly sham injections or monthly intravitreal injections of ...

Methods: The PubMed database was used to identify publications by using combinations of the search terms, "glaucoma," "ocular hypertension," "pegaptanib," "bevacizumab," "ranibizumab ...